comparemela.com

Latest Breaking News On - Kingray capital - Page 1 : comparemela.com

Chinese biopharma firm IMPACT closes $55m Series D+ round to advance cancer drugs

The Series D+ round was led by GTJA Investment Group and Beijing-based state capital investor Kingray Capital.

Leiwen chenJunshi biosciencesNational medical products administrationYangzhou guojin groupInvestment groupDrug administrationYangzhou cityLilly asia venturesNew drug applicationKingray capitalEikon therapeuticsHong kong listedWuxi apptecCenova venturesDecheng capital

Chinese biopharmaceutical firm Atom Bioscience snaps over $82m in Series D round

Biopharmaceutical firm Jiangsu Atom Bioscience and Pharmaceutical has bagged 600 million yuan ($82.8 million) in a Series D funding round.

Fund managementUnifortune investment holdings groupAtom bioscienceKaitai capitalFortune capitalKingray capital

DAS Solar bags funding and 48 more updates from Greater China worth about $853m

Previously, the Quzhou-headquartered firm secured an undisclosed sum in February, joined by China Renaissance, and CICC Capital, among others.

Sinopec groupCapital operation groupPower investment corporationIndustrial fund managementBeijing financial street capital operationKingray capitalFund managementState power investment corporationSinopec capitalHuatai zijin investmentChina renaissanceJolmo capitalHuge capitalPuhua capital

Chinese advanced polymer materials maker TopOlefin snags $139m in Series B round

TopOlefin Technology has raked in 1 billion yuan ($138.9 million) in a Series B round led by local PE investment firms Kingray Capital and Raystone Capital.

Ofound angelJiangsu libertTopolefin technologyQuzhou based topolefin technologyKingray capitalGraystone capitalShangrong capital managementHighlight capitalBiotrack capitalCobetter filtration

Chinese biotech firm Trinomab closes $104m pre-IPO round to advance product pipeline

The round was led by PE investment firm Kingray Capital and Gree Financial Investment.

Hong kongChen leiwenZhuhai gree groupJinhang groupWuxi guolian developmentAsia hillhouse capital groupTrinomab biotechKingray capitalGree financial investmentZhuhai greeEfung capitalWanguo investmentWanguo securitiesHong kong listedChina medical systemZhuhai city

vimarsana © 2020. All Rights Reserved.